Home →
Resource →
How much evidence is provided prior to approval? An updated systematic review of biosimilar applications in Europe.
How much evidence is provided prior to approval? An updated systematic review of biosimilar applications in Europe.
https://www.ideas-itn.eu/wp-content/uploads/2018/06/Johanna_Biosimilars_Forum_Oct_2017.pdf
pdf
Joahnna Mielke, Byron Jones, Franz Koenig, Bernd Jilma. 2nd Annual Biosmiliars Forum, October 2017, Budapest
Share this page
share using:
Or copy and paste this page address:
https://www.ideas-itn.eu/resources/how-much-evidence-is-provided-prior-to-approval-an-updated-systematic-review-of-biosimilar-applications-in-europe/